Literature DB >> 32383046

Variation in Colorectal Cancer Screening Practices According to Cardiovascular Disease Status and Race/Ethnicity.

Maira A Castañeda-Avila1, Kate L Lapane2, Bill M Jesdale2, Sybil L Crawford3, Mara M Epstein2,4.   

Abstract

PURPOSE: To assess current estimates of colorectal cancer (CRC) screening practices in relation to cardiovascular disease (CVD) status and whether this association varies by race/ethnicity.
METHODS: Cross-sectional analysis of the Behavioral Risk Factor Surveillance System data from 2012, 2014, 2016, and 2018 among US adults aged 50-75 years (n = 807,937). Participants' self-reported CRC screening practices were categorized as being up-to-date, not up-to-date, or never screened. Multinomial logistic regression was used to assess whether self-reported prevalent CVD was associated with CRC screening practices after adjusting for several potentially confounding variables; additional analyses were stratified by race/ethnicity.
RESULTS: One-quarter of US adults had never been screened for CRC, while 67.0% reported being up-to-date with CRC screening. The proportion of Hispanics who had never been screened (35.3%) was higher than non-Hispanic Whites (23.5%) and Blacks (20.6%). Adults with CVD were less likely to never have been screened (adjusted odds ratio (aOR), 0.92; 95% confidence interval (CI), 0.88-0.95) or not to be up-to-date (aOR, 0.90; 95% CI, 0.86-0.94) on CRC screening than those without CVD.
CONCLUSION: The presence of CVD is associated with better adherence to CRC screening guidelines. Poor CRC screening utilization in Hispanics should be a priority for further investigation and intervention.

Entities:  

Keywords:  Blacks; Cardiovascular disease; Colorectal cancer screening; Hispanics; Whites

Mesh:

Year:  2020        PMID: 32383046      PMCID: PMC7647945          DOI: 10.1007/s40615-020-00768-w

Source DB:  PubMed          Journal:  J Racial Ethn Health Disparities        ISSN: 2196-8837


  29 in total

Review 1.  Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis.

Authors:  Lukejohn W Day; Annette Kwon; John M Inadomi; Louise C Walter; Ma Somsouk
Journal:  Gastrointest Endosc       Date:  2011-10       Impact factor: 9.427

2.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

Review 3.  Health disparities in colorectal cancer among racial and ethnic minorities in the United States.

Authors:  Christian S Jackson; Matthew Oman; Aatish M Patel; Kenneth J Vega
Journal:  J Gastrointest Oncol       Date:  2016-04

4.  Opportunities to Expand Colorectal Cancer Screening Participation.

Authors:  Crystale Purvis Cooper; Cynthia A Gelb
Journal:  J Womens Health (Larchmt)       Date:  2016-10       Impact factor: 2.681

Review 5.  The Role of Patient Navigation on Colorectal Cancer Screening Completion and Education: a Review of the Literature.

Authors:  Ajeesh Sunny; Luis Rustveld
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

6.  Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.

Authors:  John M Inadomi; Sandeep Vijan; Nancy K Janz; Angela Fagerlin; Jennifer P Thomas; Yunghui V Lin; Roxana Muñoz; Chim Lau; Ma Somsouk; Najwa El-Nachef; Rodney A Hayward
Journal:  Arch Intern Med       Date:  2012-04-09

7.  Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage.

Authors:  Janet S de Moor; Robin A Cohen; Jean A Shapiro; Marion R Nadel; Susan A Sabatino; K Robin Yabroff; Stacey Fedewa; Richard Lee; V Paul Doria-Rose; Cheryl Altice; Carrie N Klabunde
Journal:  Prev Med       Date:  2018-05-03       Impact factor: 4.018

8.  Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures.

Authors:  Xue Song; Ruben G W Quek; Shravanthi R Gandra; Katherine A Cappell; Robert Fowler; Ze Cong
Journal:  BMC Health Serv Res       Date:  2015-06-25       Impact factor: 2.655

9.  Should screening for colorectal neoplasm be recommended in patients at high risk for coronary heart disease: a cross-sectional study.

Authors:  Sebahat Basyigit; Selcuk Ozkan; Metin Uzman; Derun T Ertugrul; Ayse Kefeli; Bora Aktas; Abdullah O Yeniova; Zeliha Asilturk; Yasar Nazligul; Hulya Simsek; Gulcin Simsek; Mehmet Ayturk; Bunyamin Yavuz
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

10.  Comparison of SEER Treatment Data With Medicare Claims.

Authors:  Anne-Michelle Noone; Jennifer L Lund; Angela Mariotto; Kathleen Cronin; Timothy McNeel; Dennis Deapen; Joan L Warren
Journal:  Med Care       Date:  2016-09       Impact factor: 3.178

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.